S. Sahrun and L. Wulandari, “Case report: Management of Progressive Lung Cancer Patients after First-Line EGFR Tyrosine Kinase Inhibitor Therapy”, FMI, vol. 55, no. 3, pp. 239–245, Oct. 2019.